Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to CyclophosphamideAtefeh Khodakarami, Farhad Jadidi‐Niaragh, Bentolhoda Rashidi et al.|Cell Communication and Signaling|2023Cited by 16
Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responsesSara Adibfar, Farhad Jadidi-Niaragh, Ali Masjedi et al.|Life Sciences|2022Cited by 15